2021
DOI: 10.1016/j.micpath.2021.104809
|View full text |Cite
|
Sign up to set email alerts
|

Latest updates on SARS-CoV-2 genomic characterization, drug, and vaccine development; a comprehensive bioinformatics review

Abstract: Amid the COVID-19 outbreak, several bioinformatic analyses have been conducted on SARS-CoV-2 virus genome. Numerous studies rushed to fill the gap about this novel virus. Comparison with other related sequences, structural predictions of the produced proteins, determination of variations in amino acid residues and depiction of possible drug and vaccine targets have been the focus of scientific research from the beginning of this year. In addition to discussing the viral taxonomy, clinical features, life cycle,… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
3
1
1

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(7 citation statements)
references
References 160 publications
(258 reference statements)
0
7
0
Order By: Relevance
“…The selected core genes were ADM, ARRB1, AVPR2, CCR1, MTNR1A, PTH, and S1PR2. ADM significantly alleviates renal fibrosis by inhibiting oxidative stress, gene transfer blocking renal tubular cell inflammation, and inhibiting epithelial-mesenchymal transition (EMT) (33). ADM-induced HO-1 is a potential target for the prevention and treatment of renal fibrosis in patients with CKD.…”
Section: Discussionmentioning
confidence: 99%
“…The selected core genes were ADM, ARRB1, AVPR2, CCR1, MTNR1A, PTH, and S1PR2. ADM significantly alleviates renal fibrosis by inhibiting oxidative stress, gene transfer blocking renal tubular cell inflammation, and inhibiting epithelial-mesenchymal transition (EMT) (33). ADM-induced HO-1 is a potential target for the prevention and treatment of renal fibrosis in patients with CKD.…”
Section: Discussionmentioning
confidence: 99%
“…In addition to the four structural proteins, the rest of the genome encodes six accessory proteins, ORF3a, ORF6, ORF7a, ORF7b, ORF8, and ORF10, respectively. The envelope has a coronal spike composed of the first three structural proteins [22]. One study examined 10,022 complete SARS-CoV-2 genome sequences in four databases and aligned these sequences with reference genomes, and the results indicated 5775 distinct genomic variants, and the most common variants being synonymous 3037C > T (6334 samples), P4715L in ORF1ab (6319 samples) and D614G in spike protein (6294 samples) [16].…”
Section: Structure Of Sars-cov-2mentioning
confidence: 99%
“…Several studies about the COVID 19 vaccine have been launched since 2020. There are 2 mRNA vaccines on the market and several protein vaccines [13][14][15][16][17]. These vaccines are developed on the basis of S protein and present a great protection.…”
Section: Introductionmentioning
confidence: 99%